Fundz
Real-time · AI · Cross-signal

TandemAI just raised. Here's exactly what to do next.

Who to reach, what to say, and why now — on TandemAI, plus every funding round, exec hire, and M&A move that follows. Verified, ICP-ranked contacts on demand (email + mobile).

Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.

Choose your planRequest a demo

Everyone else gives you a piece

✕Crunchbase & PitchBook list the company — No person, no timing, no opener.
✕ZoomInfo & Apollo sell you a contact — No trigger, no reason to reach out now.
✕LinkedIn Sales Navigator shows you people — No real-time signal, no opener.
✕Clay enriches lists you built — No live signal of its own, no who or when.
✕ChatGPT & gen-AI tools answer on a delay — No live data, no verified contact.
Who to contactWhat to sayWhen to reach outWhy now

Only Fundz delivers all four.

TandemAI has secured $22 million in a Series A extension to enhance its AI-driven drug discovery platform, attracting both new and existing investors.

PRIVATENov 14, 2025•7 months ago

Amount Raised

$22 Million

Round Type

SERIES A

New YorkBiotechnologyArtificial Intelligence

Description

TandemAI has announced a $22 million Series A extension to advance its drug discovery platform that uses AI and advanced computational methods. The company, founded in October 2021, has raised over $80 million so far. This funding will bolster their small molecule business and capitalize on opportunities in peptide discovery. Investors include both new and existing backers, underlining confidence in TandemAI's innovative approach.

Company Information

Company

TandemAI

Location

New York, New York, United States

About

TandemAI is an advanced technology company dedicated to reinventing drug discovery infrastructure. The company integrates proprietary AI-driven, high-performance computation with its efficient, large-scale in-house wet lab operations to deliver a turnkey drug discovery solution. TandemAI has built its networked platform from the ground up in the U.S. and China to increase the speed of drug discovery and deliver cost-effective opportunities to its partners and to the global scientific community.

Related People

Suggested for you
1 contact

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for TandemAI's next move

Learn about Strategic plan

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies.

Watching TandemAI? See every signal — funding, hires, M&A, contracts, sentiment.

Request a demoChoose your plan